InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Passage BIO, Inc.

PASG Clue Score25
United States Fiscal year ends December CIK 0001787297 Results filed 3 Mar 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

86
Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
25 Jun 2026
10% owner
Buy indirect
50,055
$4.12
$206.10K
Kathleen Borthwick
8 Jan 2026
CFO
Sold after exercise
2,062
$18.44
$38.02K
William Chou
8 Jan 2026
President and CEO
Sold after exercise
4,076
$18.44
$75.16K
Lynx1 Capital Management LP
15 Sep 2025
10% owner
Buy indirect
11,900
$6.99
$83.18K
Lynx1 Capital Management LP
12 Sep 2025
10% owner
Buy indirect
19,783
$6.99
$138.30K
Lynx1 Capital Management LP
11 Sep 2025
10% owner
Buy indirect
325
$6.96
$2.26K
Lynx1 Capital Management LP
24 Jul 2025
10% owner
Buy indirect
66,423
$5.71
$379.45K
Lynx1 Capital Management LP
23 Jul 2025
10% owner
Buy indirect
49,302
$5.74
$283.03K
Lynx1 Capital Management LP
22 Jul 2025
10% owner
Buy indirect
13,123
$5.44
$71.34K
Orbimed Advisors LLC
26 Jun 2025
10% owner
Sell indirect
213,257
$0.33
$70.37K
Orbimed Advisors LLC
25 Jun 2025
10% owner
Sell indirect
138,800
$0.33
$45.80K
Orbimed Advisors LLC
24 Jun 2025
10% owner
Sell indirect
231,600
$0.35
$81.06K
Orbimed Advisors LLC
24 Apr 2025
10% owner
Sell indirect
68,195
$0.32
$21.82K
Orbimed Advisors LLC
23 Apr 2025
10% owner
Sell indirect
89,328
$0.34
$30.37K
Orbimed Advisors LLC
22 Apr 2025
10% owner
Sell indirect
78,049
$0.34
$26.54K
Orbimed Advisors LLC
17 Apr 2025
10% owner
Sell indirect
77,090
$0.33
$25.44K
Orbimed Advisors LLC
16 Apr 2025
10% owner
Sell indirect
61,638
$0.33
$20.34K
Orbimed Advisors LLC
15 Apr 2025
10% owner
Sell indirect
10,326
$0.38
$3.92K
Kathleen Borthwick
11 Feb 2025
CFO
Sell
3,183
$0.53
$1.69K
Orbimed Advisors LLC
14 Jan 2025
10% owner
Sell indirect
79,024
$0.60
$47.41K
Orbimed Advisors LLC
13 Jan 2025
10% owner
Sell indirect
17,986
$0.64
$11.51K
Orbimed Advisors LLC
10 Jan 2025
10% owner
Sell indirect
126,209
$0.66
$83.30K
Orbimed Advisors LLC
8 Jan 2025
10% owner
Sell indirect
75,007
$0.68
$51.00K
Orbimed Advisors LLC
7 Jan 2025
10% owner
Sell indirect
52,536
$0.71
$37.30K
Orbimed Advisors LLC
6 Jan 2025
10% owner
Sell indirect
19,481
$0.77
$15.00K
Lynx1 Capital Management LP
27 Dec 2024
10% owner
Buy indirect
373,645
$0.65
$241.04K
Orbimed Advisors LLC
20 Dec 2024
10% owner
Sell indirect
230,321
$0.60
$138.19K
Orbimed Advisors LLC
11 Dec 2024
10% owner
Sell indirect
80
$0.80
$64.00
Orbimed Advisors LLC
10 Dec 2024
10% owner
Sell indirect
8,015
$0.80
$6.41K
Orbimed Advisors LLC
9 Dec 2024
10% owner
Sell indirect
54,181
$0.84
$45.51K
Orbimed Advisors LLC
6 Dec 2024
10% owner
Sell indirect
20,903
$0.82
$17.14K
Orbimed Advisors LLC
4 Dec 2024
10% owner
Sell indirect
76,200
$0.79
$60.20K
Lynx1 Capital Management LP
27 Nov 2024
10% owner
Buy indirect
29,300
$0.67
$19.66K
Lynx1 Capital Management LP
26 Nov 2024
10% owner
Buy indirect
167,055
$0.71
$118.19K
Lynx1 Capital Management LP
25 Nov 2024
10% owner
Buy indirect
259,998
$0.56
$146.66K
Orbimed Advisors LLC
19 Sep 2024
10% owner
Sell indirect
39,300
$0.71
$27.90K
Orbimed Advisors LLC
18 Sep 2024
10% owner
Sell indirect
25,631
$0.73
$18.71K
Orbimed Advisors LLC
17 Sep 2024
10% owner
Sell indirect
111,400
$0.73
$81.32K
Orbimed Advisors LLC
16 Sep 2024
10% owner
Sell indirect
63,100
$0.74
$46.69K
Mark S Forman
13 Feb 2024
Chief Medical Officer
Sell
1,638
$0.97
$1.59K
Kathleen Borthwick
13 Feb 2024
SVP, Interim CFO
Sell
1,470
$0.97
$1.43K
Mark S Forman
2 Jan 2024
Chief Medical Officer
Sell
15,813
$0.91
$14.39K
Edgar B. Cale
2 Jan 2024
GC & Corporate Secretary
Sell
15,813
$0.91
$14.39K
Kathleen Borthwick
2 Jan 2024
SVP, Interim CFO
Sell
10,672
$0.91
$9.71K
Simona King
28 Jul 2023
Chief Financial Officer
Sold after exercise
11,453
$0.88
$10.08K
Orbimed Advisors LLC
28 Jun 2023
10% owner
Buy indirect
575,195
$0.84
$483.16K
Orbimed Advisors LLC
27 Jun 2023
10% owner
Buy indirect
617,382
$0.84
$518.60K
Alexandros Fotopoulos
16 Jun 2023
Chief Technical Officer
Sell
4,052
$0.93
$3.78K
Simona King
18 Apr 2023
Chief Financial Officer
Sold after exercise
2,053
$1.05
$2.16K
Sandip Kapadia
1 Dec 2022
Director
Sell
5,000
$1.19
$5.96K
Alexandros Fotopoulos
22 Nov 2022
Chief Technical Officer
Sold after exercise
3,720
$1.33
$4.95K
Monika Maria Toernsen
19 Sep 2022
Chief Commercial Officer
Sell
1,681
$1.51
$2.54K
Orbimed Advisors LLC
4 May 2022
10% owner
Buy indirect
303,500
$1.94
$588.79K
Orbimed Advisors LLC
3 May 2022
10% owner
Buy indirect
221,500
$1.93
$427.50K
Bruce A Goldsmith
21 Mar 2022
CEO and President
Buy
10,000
$3.15
$31.50K
Orbimed Advisors LLC
20 Jan 2022
10% owner
Buy indirect
369,100
$5.42
$2.00M
Orbimed Advisors LLC
19 Jan 2022
10% owner
Buy indirect
43,300
$5.11
$221.26K
Orbimed Advisors LLC
18 Jan 2022
10% owner
Buy indirect
114,700
$5.46
$626.26K
Orbimed Advisors LLC
14 Jan 2022
10% owner
Buy indirect
10,300
$5.60
$57.68K
Orbimed Advisors LLC
13 Jan 2022
10% owner
Buy indirect
41,800
$5.52
$230.74K
Orbimed Advisors LLC
12 Jan 2022
10% owner
Buy indirect
100,000
$5.65
$565.00K
Orbimed Advisors LLC
11 Jan 2022
10% owner
Buy indirect
8,200
$5.53
$45.35K
Jill M. Quigley
8 Dec 2021
Chief Operating Officer
Exercised, kept
71,975
$0.23
$16.55K
Bruce A Goldsmith
21 May 2021
CEO and President
Buy
2,000
$13.12
$26.23K
Richard Steven Morris
21 May 2021
Chief Financial Officer
Buy
2,171
$13.82
$30.00K
Gary Romano
15 Mar 2021
Chief Medical Officer
Sold after exercise
1,617
$21.86
$35.35K
Gary Romano
15 Mar 2021
Chief Medical Officer
Sold after exercise
8,383
$20.95
$175.66K
Jill M. Quigley
20 Jan 2021
Chief Operating Officer
Sell
1,300
$30.01
$39.01K
Jill M. Quigley
14 Jan 2021
Chief Operating Officer
Sell
16,298
$30.10
$490.57K
Athena Countouriotis
24 Mar 2020
Director
Buy
10,000
$14.98
$149.75K
Edgar B. Cale
3 Mar 2020
GC and Corporate Secretary
Buy
2,000
$18.00
$36.00K
Athena Countouriotis
3 Mar 2020
Director
Buy
8,900
$18.00
$160.20K
Alexandros Fotopoulos
3 Mar 2020
Chief Technical Officer
Buy
5,500
$18.00
$99.00K
Bruce A Goldsmith
3 Mar 2020
CEO and President
Buy
1,100
$18.00
$19.80K
Saqib Islam
3 Mar 2020
Director
Buy
5,000
$18.00
$90.00K
Sandip Kapadia
3 Mar 2020
Director
Buy
5,000
$18.00
$90.00K
Richard Steven Morris
3 Mar 2020
Chief Financial Officer
Buy
400
$18.00
$7.20K
Jill M. Quigley
3 Mar 2020
Chief Operating Officer
Buy indirect
1,000
$18.00
$18.00K
Jill M. Quigley
3 Mar 2020
Chief Operating Officer
Buy
1,500
$18.00
$27.00K
Liam Ratcliffe
3 Mar 2020
Director
Buy
2,800
$18.00
$50.40K
Tadataka Yamada
3 Mar 2020
Director
Buy
6,500
$18.00
$117.00K
Patrick J Heron
3 Mar 2020
Director
Buy indirect
550,000
$18.00
$9.90M
Thomas Woiwode
3 Mar 2020
Director
Buy indirect
225,000
$18.00
$4.05M
Frazier Life Sciences IX, L.P.
3 Mar 2020
10% owner
Buy
550,000
$18.00
$9.90M
Versant Venture Capital VI, L.P.
3 Mar 2020
10% owner
Buy indirect
225,000
$18.00
$4.05M
Orbimed Advisors LLC
28 Feb 2020
10% owner
Buy indirect
373,300
$18.00
$6.72M

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,273,474
Sales filed before the plan box existed 4
History held since 2 Mar 2020